Related Experiment Video
Updated: Feb 5, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Hypertrophic cardiomyopathy
Steve R Ommen1, Rick A Nishimura
1Division of Cardiovascular Diseases and Hypertrophic Cardiomyopathy Clinic, Mayo Clinic, Rochester, Minnesota, USA.
Insights
Hypertrophic cardiomyopathy, a genetic heart condition, presents diverse symptoms and risks, including sudden death. Understanding its genetic basis and varied presentations is key for effective patient management.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is characterized by myocardial hypertrophy without a known cause.
- HCM is associated with dynamic left ventricular outflow obstruction and sudden cardiac death risk.
- Genetic mutations in cardiac sarcomere genes are recognized as the primary cause of HCM.
Purpose of the Study:
- To highlight the heterogeneity of hypertrophic cardiomyopathy.
- To underscore the challenges in managing HCM patients.
- To provide an overview of current understanding and management considerations.
Main Methods:
- Review of existing literature on hypertrophic cardiomyopathy.
- Analysis of morphologic and pathophysiological differences.
- Examination of natural history studies and treatment strategies.
Main Results:
- HCM exhibits significant heterogeneity in its presentation and progression.
- Multiple sarcomere gene mutations are implicated in HCM development.
- Disparate findings across studies complicate management.
Conclusions:
- Effective management of hypertrophic cardiomyopathy requires addressing its complex heterogeneity.
- Understanding the genetic underpinnings is crucial for personalized treatment.
- Ongoing research into natural history and novel therapies is essential.
Abstract:
Hypertrophic cardiomyopathy is a fascinating disease of marked heterogeneity. Hypertrophic cardiomyopathy was originally characterized by massive myocardial hypertrophy in the absence of known cause, a dynamic left ventricular outflow obstruction, and increased risk of sudden death. It is now well accepted that multiple mutations in genes encoding for the cardiac sarcomere are responsible for the disease. Complex morphologic and pathophysiological differences, disparate natural history studies, and novel treatment strategies underscore the challenge to the practicing cardiologist when faced with the management of the patient with hypertrophic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

